Literature DB >> 1060125

Selective effects of inhibitors of protein synthesis on metabolism of nuclear anc cytoplasmic proteins: evidence for coordinate synthesis of non-histone chromosomal proteins.

G Vidali, J Karn, V G Allfrey.   

Abstract

We have compared the effects of inhibitors of protein synthesis on the metabolism of nuclear and cytoplasmic proteins of HeLa S-3 cells. L-1-tosylamido-2-phenylethyl chloromethyl ketone, a potent inhibitor of polypeptide chain initiation, was shown to preferentially inhibit the synthesis of cytoplasmic proteins and of histones at concentrations that permit continued amino acid incorporation into nuclear non-histone proteins. Comparisons of the molecular weight distributions of newly synthesized proteins in the presence and absence of L-1-tosylamido-2-phenylethyl chloromethyl ketone have revealed striking differences between nuclear anc cytoplasmic protein fractions. Differential effects on the synthesis of cytoplasmic proteins, acid-soluble nuclear proteins, and residual nuclear proteins have also been obtained with the antibiotic, pactamycin, another inhibitor of polypeptide chain initiation. The incorporation of radioactive amino acids into nuclear non-histone proteins shows resistance to inhibition by pactamycin, but is strongly inhibited by agents such as puromycin and cycloheximide which block chain elongation. The possibility that proliferating cells have developed specialized mechanisms for the coordinate synthesis of chromosomal proteins, possibly involving polycistronic messenger RNAs, is tested and discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1060125      PMCID: PMC388739          DOI: 10.1073/pnas.72.11.4450

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Differential phosphorylation and turnover of nuclear acidic proteins during the cell cycle of synchronized HeLa cells.

Authors:  J Karn; E M Johnson; G Vidali; V G Allfrey
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

2.  Cleavage of viral precursor proteins in vivo and in vitro.

Authors:  B D Korant
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

3.  Inhibition of cleavage of large poliovirus-specific precursor proteins in infected HeLa cells by inhibitors of proteolytic enzymes.

Authors:  D F Summers; E N Shaw; M L Stewart; J V Maizel
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

Review 4.  Proteolytic processing in the biosynthesis of insulin and other proteins.

Authors:  D F Steiner; W Kemmler; H S Tager; J D Peterson
Journal:  Fed Proc       Date:  1974-10

5.  Polypeptide cleavages in the formation of poliovirus proteins.

Authors:  M F Jacobson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

6.  Nonhistone chromosomal proteins in synchronized HeLa cells.

Authors:  J S Bhorjee; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

7.  The cell-cycle phase synthesis of non-histone proteins in mammalian cells.

Authors:  E W Gerner; R M Humphrey
Journal:  Biochim Biophys Acta       Date:  1973-11-26

8.  Cell cycle dependent turnover of non-histone proteins in chromatin.

Authors:  R Tsanev; L Djondjurov; E Ivanova
Journal:  Exp Cell Res       Date:  1974-03-15       Impact factor: 3.905

9.  Letter: Effect of an inhibitor of proteolysis on the size of newly-synthesized protein in HeLa cells.

Authors:  R Taber; R Wertheimer; J Golrick
Journal:  J Mol Biol       Date:  1973-10-25       Impact factor: 5.469

10.  Selective inhibition of the synthesis of Sindbis virion proteins by an inhibitor of chymotrypsin.

Authors:  E R Pfefferkorn; M K Boyle
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

View more
  1 in total

1.  Comparative studies on the '5'-cap' and in vitro translational activity of cytoplasmic and nuclear poly A(+) RNA1.

Authors:  M S Rao; F Hirsch; B C Wu; W H Spohn; H Busch
Journal:  Mol Cell Biochem       Date:  1977-03-21       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.